- Home
- JMSB vs GALT Comparison
JMSB vs GALT Comparison
Compare JMSB & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- GALT
- Stock Information
- Founded
- JMSB 2005
- GALT 2000
- Country
- JMSB United States
- GALT United States
- Employees
- JMSB N/A
- GALT N/A
- Industry
- JMSB Major Banks
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- GALT Health Care
- Exchange
- JMSB Nasdaq
- GALT Nasdaq
- Market Cap
- JMSB 270.0M
- GALT 232.3M
- IPO Year
- JMSB N/A
- GALT N/A
- Fundamental
- Price
- JMSB $20.17
- GALT $4.60
- Analyst Decision
- JMSB Buy
- GALT Strong Buy
- Analyst Count
- JMSB 2
- GALT 3
- Target Price
- JMSB $22.50
- GALT $6.00
- AVG Volume (30 Days)
- JMSB 11.5K
- GALT 241.8K
- Earning Date
- JMSB 10-22-2025
- GALT 08-14-2025
- Dividend Yield
- JMSB 1.49%
- GALT N/A
- EPS Growth
- JMSB 688.28
- GALT N/A
- EPS
- JMSB 1.32
- GALT N/A
- Revenue
- JMSB $56,750,000.00
- GALT N/A
- Revenue This Year
- JMSB $18.36
- GALT N/A
- Revenue Next Year
- JMSB $12.36
- GALT N/A
- P/E Ratio
- JMSB $15.29
- GALT N/A
- Revenue Growth
- JMSB 59.00
- GALT N/A
- 52 Week Low
- JMSB $13.81
- GALT $0.73
- 52 Week High
- JMSB $26.52
- GALT $4.71
- Technical
- Relative Strength Index (RSI)
- JMSB 59.19
- GALT 69.41
- Support Level
- JMSB $19.19
- GALT $3.93
- Resistance Level
- JMSB $20.34
- GALT $4.35
- Average True Range (ATR)
- JMSB 0.45
- GALT 0.27
- MACD
- JMSB 0.01
- GALT 0.03
- Stochastic Oscillator
- JMSB 80.28
- GALT 91.67
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.